Skip to main content Accessibility help
×
Home
Hostname: page-component-5d6d958fb5-w6vhv Total loading time: 0.825 Render date: 2022-11-29T07:49:10.970Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "displayNetworkTab": true, "displayNetworkMapGraph": false, "useSa": true } hasContentIssue true

Part 10 - Management Misadventures

Published online by Cambridge University Press:  03 November 2020

Keith Josephs
Affiliation:
Mayo Clinic Alzheimer’s Disease Research Center
Federico Rodriguez-Porcel
Affiliation:
Medical University of South Carolina
Rhonna Shatz
Affiliation:
University of Cincinnati
Daniel Weintraub
Affiliation:
University of Pennsylvania
Alberto Espay
Affiliation:
University of Cincinnati
Get access
Type
Chapter
Information
Common Pitfalls in Cognitive and Behavioral Neurology
A Case-Based Approach
, pp. 149 - 168
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Antonini, A. et al. 2016. Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis. Eur J Neurol 23(10) 15561565.CrossRefGoogle ScholarPubMed
Bastiaens, J., Dorfman, B. J., Christos, P. J. and Nirenberg, M. J. 2013. Prospective cohort study of impulse control disorders in Parkinson’s disease. Mov Disord 28(3) 327333.CrossRefGoogle ScholarPubMed
Bereau, M. et al. 2018. Hyperdopaminergic behavioral spectrum in Parkinson’s disease: a review. Rev Neurol 174(9) 653663.CrossRefGoogle ScholarPubMed
Evans, A. H. et al. 2019. Scales to assess impulsive and compulsive behaviors in Parkinson’s disease: critique and recommendations. Mov Disord 34(6) 791798.CrossRefGoogle ScholarPubMed
Giovannoni, G. et al. 2000. Hedonistic homeostatic dysregulation in patients with Parkinson’s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68(4) 423428.CrossRefGoogle ScholarPubMed
Rabinak, C. A. and Nirenberg, M. J. 2010. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 67(1) 5863.CrossRefGoogle ScholarPubMed
Spencer, A. H., Rickards, H., Fasano, A. and Cavanna, A. E. 2011. The prevalence and clinical characteristics of punding in Parkinson’s disease. Mov Disord 26(4) 578586.CrossRefGoogle ScholarPubMed
Weintraub, D. and Claassen, D. O. 2017. Impulse control and related disorders in Parkinson’s disease. Int Rev Neurobiol 133 679717.CrossRefGoogle ScholarPubMed
Weintraub, D. et al. 2015. Clinical spectrum of impulse control disorders in Parkinson’s disease. Mov Disord 30(2) 121127.CrossRefGoogle ScholarPubMed
Weintraub, D. et al. 2009. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease. Mov Disord 24(10) 14611467.CrossRefGoogle ScholarPubMed
Weintraub, D. et al. 2010. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 67(5) 589595.CrossRefGoogle ScholarPubMed
Weintraub, D. et al. 2012. Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease Rating Scale. Mov Disord 27(2) 242247.CrossRefGoogle ScholarPubMed
Weintraub, D. et al. 2010. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol 68(6) 963968.CrossRefGoogle ScholarPubMed

Reference

Daiello, L. A. et al. 2009. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia. Am J Geriatr Pharmacother 7(2) 7483.CrossRefGoogle ScholarPubMed
Doody, R. S. et al. 2001. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol 58(3) 427433.CrossRefGoogle ScholarPubMed
Ferris, S. H. and Farlow, M. 2013. Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors. Clin Interv Aging 8 10071014.CrossRefGoogle ScholarPubMed
Howard, R. et al. 2012. Donepezil and memantine for moderate-to-severe Alzheimer’s disease. N Engl J Med 366(10) 893903.CrossRefGoogle ScholarPubMed
Lanctôt, K. et al. 2015. Predictors of worsening following cholinesterase inhibitor discontinuation trial in institutionalized persons with moderate to severe Alzheimer’s disease: results of a double-blind, placebo controlled trial. Alzheimer’s Dementia 11(7) P520.CrossRefGoogle Scholar
Pariente, A. et al. 2012. Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors. Neurology 78(13) 957963.CrossRefGoogle ScholarPubMed
Scarpini, E. et al. 2011. Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer’s disease: a randomized, double blind, placebo controlled withdrawal trial. J Alzheimers Dis 26(2) 211220.CrossRefGoogle ScholarPubMed

References

Brasure, M. et al. 2016. AHRQ comparative effectiveness reviews. In Nonpharmacologic Interventions for Agitation and Aggression in Dementia. Rockville, MD: Agency for Healthcare Research and Quality, pp. 1263.Google ScholarPubMed
Gitlin, L. N. et al. 2008. Tailored activities to manage neuropsychiatric behaviors in persons with dementia and reduce caregiver burden: a randomized pilot study. Am J Geriatr Psychiatry 16(3) 229239.CrossRefGoogle ScholarPubMed
Gitlin, L. N. et al. 2010. A biobehavioral home-based intervention and the well-being of patients with dementia and their caregivers: the COPE randomized trial. JAMA 304(9) 983991.CrossRefGoogle ScholarPubMed
Kales, H. C. et al. 2014. Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc 62(4) 762769.CrossRefGoogle ScholarPubMed
Livingston, G. et al. 2014. Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials. Br J Psychiatry 205(6) 436442.CrossRefGoogle ScholarPubMed
Schneider, L. S. et al. 2006. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. New Engl J Med 355(15) 15251538.CrossRefGoogle ScholarPubMed
Sink, K. M., Holden, K. F. and Yaffe, K. 2005. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 293(5) 596608.CrossRefGoogle Scholar
Tible, O. P., Riese, F., Savaskan, E. and von Gunten, A. 2017. Best practice in the management of behavioural and psychological symptoms of dementia. Ther Adv Neurol Disord 10(8) 297309.CrossRefGoogle ScholarPubMed
Van Den Wijngaart, M. A., Vernooij-Dassen, M. J. and Felling, A. J. 2007. The influence of stressors, appraisal and personal conditions on the burden of spousal caregivers of persons with dementia. Aging Ment Health 11(6) 626636.CrossRefGoogle ScholarPubMed
Yaffe, K. et al. 2002. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 287(16) 20902097.CrossRefGoogle ScholarPubMed

References

Brown, L. B. et al. 2005. Prediction of on-road driving performance in patients with early Alzheimer’s disease. J Am Geriatr Soc 53(1) 9498.CrossRefGoogle ScholarPubMed
Dubinsky, R. M., Stein, A. C. and Lyons, K. 2000. Practice parameter: risk of driving and Alzheimer’s disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 54(12) 22052211.CrossRefGoogle ScholarPubMed
Esser, P. et al. 2016. Utility of the MOCA as a cognitive predictor for fitness to drive. J Neurol Neurosurg Psychiatry 87(5) 567568.CrossRefGoogle ScholarPubMed
Flemons, W. W., Remmers, J. E. and Whitelaw, W. A. 1993. The correlation of a computer simulated driving program with polysomnographic indices and neuropsychological tests in consecutively referred patients for assessment of sleep apnea. Sleep 16(8 Suppl) S71.CrossRefGoogle ScholarPubMed
Iverson, D. J. et al. 2010. Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74(16) 13161324.CrossRefGoogle ScholarPubMed
Ohayon, M. M. and Vecchierini, M. F. 2002. Daytime sleepiness and cognitive impairment in the elderly population. Arch Intern Med 162(2) 201208.CrossRefGoogle ScholarPubMed
Strohl, K. P. et al. 2013. An official American Thoracic Society Clinical Practice Guideline: sleep apnea, sleepiness, and driving risk in noncommercial drivers. An update of a 1994 Statement. Am J Respir Crit Care Med 187(11) 12591266.CrossRefGoogle ScholarPubMed
Taylor, B. D. and Tripodes, S. 2001. The effects of driving cessation on the elderly with dementia and their caregivers. Accid Anal Prev 33(4) 519528.CrossRefGoogle ScholarPubMed

References

Espay, A. J. et al. 2017. Deconstructing normal pressure hydrocephalus: ventriculomegaly as early sign of neurodegeneration. Ann Neurol 82(4) 503513.CrossRefGoogle ScholarPubMed
Graff-Radford, N. R. and Jones, D. T. 2019. Normal pressure hydrocephalus. Continuum 25(1) 165186.Google ScholarPubMed
Halperin, J. J. et al. 2015. Practice guideline: idiopathic normal pressure hydrocephalus: response to shunting and predictors of response: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 85(23) 20632071.CrossRefGoogle ScholarPubMed
Ishii, K. et al. 2008. Clinical impact of the callosal angle in the diagnosis of idiopathic normal pressure hydrocephalus. Eur Radiol 18(11) 26782683.CrossRefGoogle Scholar
Klassen, B. T. and Ahlskog, J. E. 2011. Normal pressure hydrocephalus: how often does the diagnosis hold water? Neurology 77(12) 11191125.CrossRefGoogle ScholarPubMed
Oliveira, L. M., Nitrini, R. and Roman, G. C. 2019. Normal-pressure hydrocephalus: a critical review. Dement Neuropsychol 13(2) 133143.CrossRefGoogle ScholarPubMed
Ringstad, G., Vatnehol, S. A. S. and Eide, P. K. 2017. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain 140(10) 26912705.CrossRefGoogle ScholarPubMed
Roman, G. C., Verma, A. K., Zhang, Y. J. and Fung, S. H. 2018. Idiopathic normal-pressure hydrocephalus and obstructive sleep apnea are frequently associated: a prospective cohort study. J Neurol Sci 395 164168.CrossRefGoogle ScholarPubMed
Starr, B. W., Hagen, M. C. and Espay, A. J. 2014. Hydrocephalic Parkinsonism: lessons from normal pressure hydrocephalus mimics. J Clin Mov Disord 1 2.CrossRefGoogle ScholarPubMed

References

Akbaraly, T. N. et al. 2009. Leisure activities and the risk of dementia in the elderly: results from the Three-City Study. Neurology 73(11) 854861.CrossRefGoogle ScholarPubMed
Fotuhi, M., Do, D. and Jack, C. 2012. Modifiable factors that alter the size of the hippocampus with ageing. Nature Reviews Neurology 8 189.CrossRefGoogle ScholarPubMed
Hughes, C. P. et al. 1982. A new clinical scale for the staging of dementia. Br J Psychiatry 140 566572.CrossRefGoogle ScholarPubMed
Karssemeijer, E. G. A. et al. 2017. Positive effects of combined cognitive and physical exercise training on cognitive function in older adults with mild cognitive impairment or dementia: a meta-analysis. Ageing Res Rev 40 7583.CrossRefGoogle ScholarPubMed
Kuiper, J. S. et al. 2015. Social relationships and risk of dementia: a systematic review and meta-analysis of longitudinal cohort studies. Ageing Res Rev 22 3957.CrossRefGoogle ScholarPubMed
Livingston, G. et al. 2017. Dementia prevention, intervention, and care. Lancet 390(10113) 26732734.CrossRefGoogle ScholarPubMed
Morris, M. C. et al. 2015a. MIND diet slows cognitive decline with aging. Alzheimers Dement 11(9) 10151022.CrossRefGoogle ScholarPubMed
Morris, M. C. et al. 2015b. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement 11(9) 10071014.CrossRefGoogle ScholarPubMed
Petersen, R. C. et al. 2018. Practice guideline update summary: mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 90(3) 126135.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×